|
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of drug treatments for mental illnesses.
Created January 2008
Printer friendly page
| Results 1 to 11 displayed. |
| Title: |
Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Tardive dyskinesia is a disfiguring and disabling movement disorder which is often caused by drugs used to treat schizophrenia. Several of the Cochrane reviews have summarised the effects of the many treatments used to manage these involuntary movements...
|
| Date: |
Oct 2005
|
| Title: |
Cholinergic medication for neuroleptic-induced tardive dyskinesia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Drug-induced tardive dyskinesia is a common adverse effect of some antipsychotics, especially when these are given for an extended period of time. Tardive dyskinesia consists of involuntary repetitive movements, mainly in the oral region, but sometimes ...
|
| Date: |
May 2002
|
| Title: |
Sulpiride for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
The aim of this review is to estimate the clinical efficacy and tolerability of sulpiride.
|
| Title: |
Miscellaneous treatments for neuroleptic-induced tardive dyskinesia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Tardive dyskinesia is a disfiguring and disabling disorder of voluntary control of movement often caused by antipsychotic drugs. Several Cochrane reviews have summarised the effects of the many treatments used to manage these involuntary movements. This...
|
| Date: |
Jan 2003
|
| Title: |
Carbamazepine for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Carbamazepine is an antiepileptic drug, which is also used as an adjunct to antipsychotics for schizophrenia. Although the original patient data from eight out of ten included studies could be re-analysed, we found no significant benefit of carbamazepin...
|
| Date: |
May 2007
|
| Title: |
Calcium channel blockers for neuroleptic-induced tardive dyskinesia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Antipsychotic medication is associated with adverse effects, including tardive dyskinesia which is characterised by abnormal, repetitive, involuntary facial movements. Calcium channel blockers, originally developed for use in cardiovascular disorders, h...
|
| Date: |
Oct 2003
|
| Title: |
Vitamin E for neuroleptic-induced tardive dyskinesia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Having to take antipsychotic drugs for long periods of time can cause repetitive movements - often of the face and mouth. These are disfiguring and do not necessarily cease once medication is reduced or changed. Vitamin E has been evaluated for treating...
|
| Date: |
Aug 2001
|
| Title: |
Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Some limited evidence from trials suggest zuclopenthixol decanoate may prevent or postpone relapses better than other depot (long-lasting) drugs for schizophrenia, but it may have more adverse effects and more research is needed
|
| Results 1 to 11 displayed. |
|